Chemoradiotherapy With Very Low Dose Elective Nodal IMRT for Locally Advanced Head & Neck Cancer: the CCRO11 Multi-Institutional Phase II Trial
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
To assess the actuarial elective nodal failure (ENF) rate for patients with locally advanced HNSCC treated with chemoRT including very low dose elective nodal IMRT and concurrent weekly cisplatin.
Patrick D. Maguire, M.D.
Coastal Carolina Radiation Oncology
United States: Institutional Review Board
|CarolinaEast Cancer Care||New Bern, North Carolina 28560|
|Coastal Carolina Radiation Oncology||Wilmington, North Carolina 28401|
|Coleman Radiation Oncology Center||Morehead City, North Carolina 28557|
|South Atlantic Radiation Oncology||Supply, North Carolina 28462|
|Zimmer Cancer Center||Wilmington, North Carolina 28401|